Compare SRPT & TALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRPT | TALO |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2000 | 2017 |
| Metric | SRPT | TALO |
|---|---|---|
| Price | $16.17 | $13.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 5 |
| Target Price | ★ $25.85 | $18.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.7M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | ★ $2,198,237,000.00 | $1,780,070,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.56 | ★ N/A |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $7.67 |
| 52 Week High | $25.32 | $17.05 |
| Indicator | SRPT | TALO |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 37.04 |
| Support Level | $15.10 | $10.49 |
| Resistance Level | $18.16 | $13.85 |
| Average True Range (ATR) | 0.79 | 0.53 |
| MACD | 0.18 | -0.10 |
| Stochastic Oscillator | 42.57 | 7.39 |
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.